Lorazepam Tablet
Product Images NDC 71610-827

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0827 10)

Lorazepam, USP 0.5 mg oral tablets, supplied in a 10-tablet package. The label includes storage instructions to keep between 20-25 degrees Celsius, caution to store in a light-resistant container, and a warning that it may be habit forming. The manufacturer is New England Laboratories Inc., with Aphena Pharma Solutions - Tennessee, LLC as the labeler. The NDC is 71610-827-10.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

1 (Spl Lorazepam Tablet Structure)

Chemical structure of lorazepam, showing its molecular arrangement including two chlorinated benzene rings connected to a diazepine ring with hydroxyl and ketone functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.